Novel Agent Reduces Need for Transfusion in MDSNovel Agent Reduces Need for Transfusion in MDS

The first-in-class investigational agent sotatercept reduced the transfusion burden in ESA-refractory, anemic, lower-risk patients with myelodysplastic syndromes (MDS). Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news